SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 168 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $21,000 | -64.4% | 16,458 | -39.1% | 0.00% | -50.0% |
Q3 2021 | $59,000 | -49.6% | 27,012 | -13.5% | 0.00% | -50.0% |
Q2 2021 | $117,000 | +36.0% | 31,243 | +18.1% | 0.00% | +33.3% |
Q1 2021 | $86,000 | -2.3% | 26,449 | +2.4% | 0.00% | -25.0% |
Q4 2020 | $88,000 | +2.3% | 25,827 | +23.0% | 0.00% | 0.0% |
Q3 2020 | $86,000 | +43.3% | 20,992 | +18.5% | 0.00% | +33.3% |
Q2 2020 | $60,000 | +71.4% | 17,717 | +17.1% | 0.00% | 0.0% |
Q1 2020 | $35,000 | -50.0% | 15,133 | -21.4% | 0.00% | 0.0% |
Q4 2019 | $70,000 | -53.3% | 19,255 | +6.6% | 0.00% | -62.5% |
Q3 2019 | $150,000 | -5.7% | 18,061 | -2.1% | 0.01% | 0.0% |
Q2 2019 | $159,000 | -23.2% | 18,445 | -4.8% | 0.01% | -20.0% |
Q1 2019 | $207,000 | -24.7% | 19,380 | -38.3% | 0.01% | -41.2% |
Q4 2018 | $275,000 | -55.0% | 31,401 | -13.7% | 0.02% | -26.1% |
Q3 2018 | $611,000 | +48.3% | 36,369 | +85.1% | 0.02% | +43.8% |
Q2 2018 | $412,000 | +45.6% | 19,648 | +11.7% | 0.02% | +45.5% |
Q1 2018 | $283,000 | +6.8% | 17,593 | +25.8% | 0.01% | +10.0% |
Q4 2017 | $265,000 | +34.5% | 13,983 | -0.3% | 0.01% | +25.0% |
Q3 2017 | $197,000 | +131.8% | 14,030 | +22.5% | 0.01% | +100.0% |
Q2 2017 | $85,000 | -16.7% | 11,453 | -27.3% | 0.00% | -20.0% |
Q1 2017 | $102,000 | +4.1% | 15,752 | -28.8% | 0.01% | 0.0% |
Q4 2016 | $98,000 | +53.1% | 22,132 | +61.8% | 0.01% | +66.7% |
Q3 2016 | $64,000 | -40.7% | 13,676 | -16.5% | 0.00% | -40.0% |
Q2 2016 | $108,000 | +9.1% | 16,381 | +5.2% | 0.01% | 0.0% |
Q1 2016 | $99,000 | +20.7% | 15,564 | +30.5% | 0.01% | +66.7% |
Q2 2015 | $82,000 | -1.2% | 11,930 | -12.5% | 0.00% | 0.0% |
Q1 2015 | $83,000 | -33.6% | 13,630 | -11.6% | 0.00% | -40.0% |
Q2 2014 | $125,000 | +0.8% | 15,411 | -2.4% | 0.01% | -16.7% |
Q1 2014 | $124,000 | -25.7% | 15,798 | -16.1% | 0.01% | -14.3% |
Q4 2013 | $167,000 | +41.5% | 18,822 | +33.7% | 0.01% | +16.7% |
Q3 2013 | $118,000 | +35.6% | 14,078 | +20.8% | 0.01% | 0.0% |
Q2 2013 | $87,000 | – | 11,656 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |